$SRPT
看空2023-05-12各周期结果✗ 踏空+23.6%
1d
✗ +5.1%
5d
✗ +5.0%
21d
✗ +23.6%
原帖
Andy Biotech · 2023-05-12
$SRPT FDA summary slides today emphasizes the key point that "Patients likely have only one chance to receive an AAV vector-based gene therapy for DMD", which could drive the panel discussion today to wait for Ph3 data that will be available later this year. https://t.co/qu52eGUpBQ
在 X 查看 ↗